Unknown

Dataset Information

0

Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.


ABSTRACT: BACKGROUND:The association between longitudinal changes in serum glucose level and longitudinal changes in [18F] Fluorodeoxyglucose-PET (FDG PET) measurements of Alzheimer's disease (AD) risk are unknown. OBJECTIVE:To investigate whether variation in serum glucose levels across time are associated with changes in FDG PET measurements of cerebral metabolic rate for glucose (rCMRgl) in brain regions preferentially affected by Alzheimer's disease (AD). METHODS:Participants are a subset of a prospective cohort study investigating FDG PET, apolipoprotein E (APOE) ?4, and risk for AD which includes data from baseline, interim, and follow up visits over 4.4±1.0-years. An automated brain-mapping algorithm was utilized to characterize and compare associations between longitudinal changes in serum glucose levels and longitudinal changes in rCMRgl. RESULTS:This study included 80 adults aged 61.5±5 years, including 38 carriers and 42 non-carriers of the APOE ?4 allele. Longitudinal increases in serum glucose levels were associated with longitudinal CMRgl decline in the vicinity of parietotemporal, precuneus/posterior cingulate, and prefrontal brain regions preferentially affected by AD (p?

SUBMITTER: Burns CM 

PROVIDER: S-EPMC6571123 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.

Burns Christine M CM   Kaszniak Alfred W AW   Chen Kewei K   Lee Wendy W   Bandy Daniel J DJ   Caselli Richard J RJ   Reiman Eric M EM  

Journal of Alzheimer's disease : JAD 20180101 2


<h4>Background</h4>The association between longitudinal changes in serum glucose level and longitudinal changes in [18F] Fluorodeoxyglucose-PET (FDG PET) measurements of Alzheimer's disease (AD) risk are unknown.<h4>Objective</h4>To investigate whether variation in serum glucose levels across time are associated with changes in FDG PET measurements of cerebral metabolic rate for glucose (rCMRgl) in brain regions preferentially affected by Alzheimer's disease (AD).<h4>Methods</h4>Participants are  ...[more]

Similar Datasets

| S-EPMC2936690 | biostudies-literature
2016-03-03 | GSE78871 | GEO
| S-EPMC3662330 | biostudies-literature
2013-12-18 | E-GEOD-53439 | biostudies-arrayexpress
| S-EPMC3838776 | biostudies-literature
2013-10-09 | GSE51309 | GEO
2013-12-18 | GSE53439 | GEO
| S-EPMC5576993 | biostudies-literature
2013-10-09 | E-GEOD-51309 | biostudies-arrayexpress
| PRJNA314239 | ENA